Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
-
Published:2021-01-25
Issue:2
Volume:27
Page:289-300
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Jerby-Arnon LivnatORCID, Neftel Cyril, Shore Marni E., Weisman Hannah R., Mathewson Nathan D.ORCID, McBride Matthew J., Haas Brian, Izar BenjaminORCID, Volorio Angela, Boulay Gaylor, Cironi Luisa, Richman Alyssa R., Broye Liliane C., Gurski Joseph M.ORCID, Luo Christina C., Mylvaganam Ravindra, Nguyen Lan, Mei Shaolin, Melms Johannes C., Georgescu Christophe, Cohen Ofir, Buendia-Buendia Jorge E., Segerstolpe Asa, Sud Malika, Cuoco Michael S.ORCID, Labes Danny, Gritsch Simon, Zollinger Daniel R., Ortogero Nicole, Beechem Joseph M., Petur Nielsen G., Chebib Ivan, Nguyen-Ngoc Tu, Montemurro Michael, Cote Gregory M., Choy EdwinORCID, Letovanec Igor, Cherix StéphaneORCID, Wagle Nikhil, Sorger Peter K.ORCID, Haynes Alex B., Mullen John T., Stamenkovic Ivan, Rivera Miguel N., Kadoch CigallORCID, Wucherpfennig Kai W., Rozenblatt-Rosen OritORCID, Suvà Mario L.ORCID, Riggi NicolòORCID, Regev AvivORCID
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference81 articles.
1. Trujillo, J. A., Sweis, R. F., Bao, R. & Luke, J. J. T cell–inflamed versus non-T cell–inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selection. Cancer Immunol. Res. 6, 990 (2018). 2. Fridman, W. H., Pagès, F., Sautès-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298–306 (2012). 3. Pollack, S. M. et al. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas. Cancer 123, 3291–3304 (2017). 4. Nielsen, T. O., Poulin, N. M. & Ladanyi, M. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov. 5, 124–134 (2015). 5. Pollack, S. M. The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients. Expert Rev. Vaccines 17, 107–114 (2018).
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|